538 related articles for article (PubMed ID: 26511530)
41. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
42. Eye-preservation treatment of retinoblastoma with vitreous seeding.
Kaneko A; Suzuki S
Jpn J Clin Oncol; 2003 Dec; 33(12):601-7. PubMed ID: 14769836
[TBL] [Abstract][Full Text] [Related]
43. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
[TBL] [Abstract][Full Text] [Related]
44. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
45. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
Stathopoulos C; Gaillard MC; Moulin A; Puccinelli F; Beck-Popovic M; Munier FL
Retina; 2019 Dec; 39(12):2273-2282. PubMed ID: 30312257
[TBL] [Abstract][Full Text] [Related]
46. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
[TBL] [Abstract][Full Text] [Related]
47. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
49. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
50. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.
Abramson DH; Marr BP; Dunkel IJ; Brodie S; Zabor EC; Driscoll SJ; Gobin YP
Br J Ophthalmol; 2012 Apr; 96(4):499-502. PubMed ID: 22053101
[TBL] [Abstract][Full Text] [Related]
51. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding.
Cieślik K; Rogowska A; Danowska M; Hautz W
Adv Clin Exp Med; 2024 Feb; 33(2):119-125. PubMed ID: 37260052
[TBL] [Abstract][Full Text] [Related]
55. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
56. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
Rao R; Honavar SG; Sharma V; Reddy VAP
Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
[TBL] [Abstract][Full Text] [Related]
57. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.
Amram AL; Rico G; Kim JW; Chintagumpala M; Herzog CE; Gombos DS; Chévez-Barrios P
Ophthalmology; 2017 Oct; 124(10):1540-1547. PubMed ID: 28528011
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
59. Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
Valente P; De Ioris MA; Romanzo A; Cozza R; Natali G; Buzzonetti L
Can J Ophthalmol; 2016 Apr; 51(2):e40-3. PubMed ID: 27085272
[No Abstract] [Full Text] [Related]
60. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
